Harpreet S. Bajaj - Publications, H-index & Citations

Harpreet S. Bajaj

LMC Diabetes and Endocrinology

37H指数

209论文数

8.9K被引数

收录论文 58

发表时间

Insulin Efsitora Demonstrates Similar Efficacy and Safety Profiles to Insulin Icodec in Insulin-Experienced Individuals With Type 2 Diabetes Mellitus: Matching-Adjusted Indirect Comparisons of QWINT-3 Versus ONWARDS 2, and QWINT-4 Versus ONWARDS 4 胰岛素Efsitora在具有胰岛素使用经验的2型糖尿病受试者中展现出与胰岛素Icodec相似的有效性和安全性特征：QWINT-3与ONWARDS 2以及QWINT-4与ONWARDS 4的匹配调整间接比较

DIABETES OBESITY & METABOLISM

IF5.7

2026-09-02

OAAI

Harpreet S. Bajaj; Marvin Fischer; Michael B. Davidson; Abdul M. Tarafder; Christopher J. Michaels; Rachel H. Tao; Alex Pashley; Jess Amis; Josefine Redig

Exercise or Fasting in Individuals With Type 2 Diabetes Receiving Once-Weekly Basal Insulin Icodec 2型糖尿病患者在每周一次基础胰岛素icodec治疗期间进行运动或禁食

DIABETES OBESITY & METABOLISM

IF5.7

2026-08-05

OAAI

Thomas R. Pieber; Harpreet S. Bajaj; Gabriele Fluhr; Klara R. Klein; Thaís M. Pagliaro Rocha; Harald Sourij; Eva Svehlikova; Keerthana Udupa; Sara K. Watt; Maria Willerslev-Olsen; Rasmus Ribel-Madsen

Correction: Reimbursement restrictions reduce liver fibrosis screening in adults with diabetes in Ontario: a population-based interrupted time series analysis 更正：报销限制减少了安大略省糖尿病患者中的肝纤维化筛查：一项基于人群的间断时间序列分析

Scientific Reports

IF3.9

2026-08-04

OAAI

Jessica Burnside; Maya Djerboua; Jennifer A. Flemming; Giada Sebastiani; William W. L. Wong; Zihang Lu; Harpreet S. Bajaj; Keyur Patel; Mia Biondi; Michael Betel; Amy Nahwegahbow; Zoë R. Greenwald; Erica E. M. Moodie; Sahar Saeed

Tirzepatide as an Add-on for Participants with Inadequate Glycemic Control Using Basal Insulin: Pooled Subgroup Analysis of SURPASS-5 and -6 tirzepatide作为使用基础胰岛素且血糖控制不佳参与者的加用药物：SURPASS-5和-6的合并亚组分析

Diabetes Therapy

IF2.6

2026-04-10

OAAI

Harpreet S. Bajaj; Liana K. Billings; Palash Sharma; Joshua A. Levine; Angel Rodriguez; Hiren Patel

1378 Efficacy and hypoglycemia outcomes with once-weekly insulin icodec vs once-daily basal insulin in type 2 diabetes by kidney function: ONWARDS 1-5 1378 一周一次胰岛素icodec与一天一次基础胰岛素在肾功能不同的2型糖尿病患者中的疗效和低血糖结局：ONWARDS 1-5

Journal of the American Pharmacists Association

IF2.5

2025-09-23

PREAI

A.Y.Y. Cheng; B. Kumar; C. Laugesen; M. Benamar; P. Rossing; Stephanie Nichols; H.S. Bajaj

1379 Efficacy and Safety of Once-Weekly Insulin Efsitora Alfa in Insulin-Naive Adults with Type 2 Diabetes: The QWINT-2 Study 1379 评估每周一次胰岛素Efsitora Alfa在胰岛素初治的2型糖尿病成人中的有效性与安全性：QWINT-2研究

Journal of the American Pharmacists Association

IF2.5

2025-09-23

PREAI

K. Syring; A. Goldyn; A. Kiyosue; C. Wysham; C. Zhou; D. Reise; D. Dahl; H. Bajaj; L.F. Gonçalves; M. Case; S. Del Prato

Adherence to app-based dose guidance for once-weekly insulin icodec in insulin-naive individuals with type 2 diabetes: Post hoc analysis of ONWARDS 5 应用基于应用程序的剂量指导对胰岛素初治的2型糖尿病患者每周一次胰岛素icodec的依从性：ONWARDS 5的事后分析

diabetes obesity metabolism

IF0

2025-08-13

PREAI

Harpreet S. Bajaj MD; Lars Villads Bennedsen MD; Anders Meller Donatsky MD; Johannes Handberg Juul Martiny PhD; André Vianna MD; Ildiko Lingvay MD

Clinical Use of Once-Weekly Insulin Icodec: Translating Clinical Trial Data into Practical Guidance for Diabetes Management 每周一次胰岛素icodec的临床应用：将临床试验数据转化为糖尿病管理的实用指南

Drugs

IF14.4

2025-08-13

OAAI

Athena Philis-Tsimikas; Jens Aberle; Harpreet Bajaj; Ildiko Lingvay; Yiming Mu; Shehla Shaikh; André Vianna; Hirotaka Watada; Stefano Del Prato

Continuous glucose monitoring in noninsulin-treated type 2 diabetes: A critical review of reported trials with an updated systematic review and meta-analysis of randomised controlled trials 非胰岛素治疗的2型糖尿病中的连续血糖监测：一项对报告试验的批判性综述，并包含随机对照试验的更新系统综述和荟萃分析

diabetes obesity metabolism

IF0

2025-08-04

OAAI

Ronnie Aronson MD; Alexander Abitbol MD; Harpreet S. Bajaj MD; Alice Y. Y. Cheng MD; Stavroula Christopoulos MD; Stewart B. Harris MD; Akshay B. Jain MD; Ronald M. Goldenberg MD

Efficacy and hypoglycaemia outcomes with once-weekly insulin icodec versus once-daily basal insulin in individuals with type 2 diabetes by kidney function: A post hoc participant-level analysis of the ONWARDS 1-5 trials

DIABETES OBESITY & METABOLISM

IF5.7

2025-02-10

OAAI

Rossing, Peter; Benamar, Malik; Cheng, Alice Y. Y.; Kumar, Bharath; Laugesen, Christian; Bajaj, Harpreet S.

Once-weekly insulin icodec compared with daily basal insulin analogues in type 2 diabetes: Participant-level meta-analysis of the ONWARDS 1-5 trials 每周一次胰岛素icodec与每日基础胰岛素类似物治疗2型糖尿病的比较: 对1-5项试验的参与者水平荟萃分析

DIABETES OBESITY & METABOLISM

IF5.7

2024-07-01

OAAI

Bajaj, Harpreet S.; Asbjoernsdottir, Bjoerg; Bari, Tanvir J.; Begtrup, Kamilla; Vilsboll, Tina; Rosenstock, Julio

Adherence to App-Based Dose Guidance for Once-Weekly Insulin Icodec in Insulin-Naive Type 2 Diabetes-Post Hoc Analysis of ONWARDS 5

DIABETES

IF7.5

2024-06-14

PREAI

Bajaj, Harpreet S.; Donatsky, Anders M.; Engberg, Susanne; Martiny, Johannes H. J.; Vianna, Andre G.; Lingvay, Ildiko

Impact of Sotagliflozin, a Dual Sodium-Glucose Cotransporter 1/2 Inhibitor, as Add-on to Inadequately Controlled Basal Insulin-Treated Type 2 Diabetes

DIABETES

IF7.5

2024-06-14

PREAI

Rosenstock, Julio; Carroll, Amy K.; Hardin, Marquette B.; Banks, Phillip L.; Buse, John B.; Davies, Melanie J.; Bajaj, Harpreet S.; Peters, Anne L.

Tirzepatide as an Add-on for Participants with Inadequate Glycemic Control Using Basal Insulin-Pooled Subgroup Analysis of SURPASS-5 and-6

DIABETES

IF7.5

2024-06-14

PREAI

Bajaj, Harpreet S.; Billings, Liana K.; Liu, Minzhi; Levine, Joshua A.; Rodriguez, Angel; Patel, Hiren

Efficacy and Safety of Once-Weekly Insulin Icodec vs. Once-Daily Basal Insulin in Individuals with Type 2 Diabetes by Kidney Function-ONWARDS 1-5

DIABETES

IF7.5

2024-06-14

PREAI

Rossing, Peter; Benamar, Malik; Cheng, Alice Y. Y.; Laugesen, Christian; Nielsen, Pernille Hojlund; Bajaj, Harpreet S.

Clinical perspectives on the frequency of hypoglycemia in treat-to-target randomized controlled trials comparing basal insulin analogs in type 2 diabetes: a narrative review

BMJ OPEN DIABETES RESEARCH & CARE

IF4.1

2024-05-14

OAAI

Rosenstock, Julio; Bajaj, Harpreet S.; Lingvay, Ildiko; Heller, Simon R.

Continuous Glucose Monitoring-Based Metrics and Hypoglycemia Duration in Insulin-Experienced Individuals With Long-standing Type 2 Diabetes Switched From a Daily Basal Insulin to Once-Weekly Insulin Icodec: Post Hoc Analysis of ONWARDS 2 and ONWARDS 4

DIABETES CARE

IF16.6

2024-02-21

OAAI

Bajaj, Harpreet S.; Asbjornsdottir, Bjorg; Carstensen, Lisbeth; Laugesen, Christian; Mathieu, Chantal; Philis-Tsimikas, Athena; Battelino, Tadej

Primary and Secondary Cardiovascular and Kidney Prevention With Canagliflozin: Insights From the CANVAS Program and CREDENCE Trial

JOURNAL OF THE AMERICAN HEART ASSOCIATION

IF5.3

2024-02-06

OAAI

Sharma, Abhinav; Razaghizad, Amir; Joury, Abdulaziz; Levin, Adeera; Bajaj, Harpreet S.; Mancini, G. B. John; Wong, Norman C.; Slee, April; Ang, Fernando G.; Rapattoni, Wally; Neuen, Brendon L.; Arnott, Clare; Perkovic, Vlado; Mahaffey, Kenneth W.

Impact of Canagliflozin on Kidney and Cardiovascular Outcomes by Type 2 Diabetes Duration: A Pooled Analysis of the CANVAS Program and CREDENCE Trials

DIABETES CARE

IF16.6

2024-01-22

OAAI

Tobe, Sheldon W.; Mavrakanas, Thomas A.; Bajaj, Harpreet S.; Levin, Adeera; Tangri, Navdeep; Slee, April; Neuen, Brendon L.; Perkovic, Vlado; Mahaffey, Kenneth W.; Rapattoni, Wally; Ang, Fernando G.

Once-Weekly Insulin Icodec With Dosing Guide App Versus Once-Daily Basal Insulin Analogues in Insulin-Naive Type 2 Diabetes (ONWARDS 5) A Randomized Trial

ANNALS OF INTERNAL MEDICINE

IF15.2

2023-11-01

PREAI

Bajaj, Harpreet S.; Aberle, Jens; Davies, Melanie; Donatsky, Anders Meller; Frederiksen, Marie; Yavuz, Dilek G.; Gowda, Amoolya; Lingvay, Ildiko; Bode, Bruce

研究方向